Economic evaluation of major selective serotonin-reuptake inhibitors in a managed care population.

Managed care interface

Volumn 14, Issue 4, 2001, Pages 59-65

  Panzarino Jr , P J ^a   Xuan, J ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADOLESCENT; ADULT; ARTICLE; COMPARATIVE STUDY; DEPRESSION; DRUG COST; ECONOMICS; EVALUATION; HEALTH INSURANCE; HUMAN; MIDDLE AGED; PATIENT CARE; UNITED STATES;

ADOLESCENT; ADULT; DEPRESSIVE DISORDER; DRUG COSTS; EPISODE OF CARE; FLUOXETINE; HUMANS; MANAGED CARE PROGRAMS; MIDDLE AGED; PAROXETINE; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; UNITED STATES;

EID: 0035316573     PISSN: 10965645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)